Upregulation of MHC-II expression enhances antigen presentation and prevents tumor immune escape [73, 74] regarding adaptive immune responses, in which the Src-family tyrosine kinase LCK [75] activates T cell receptors and enhances immune responses [76]. Here, LCK is linked to neoplasm.